SCHEMBL19475331

SCHEMBL19475331

Nc1ccc(-c2cc(C(=O)O)c3cc(Cl)ccc3n2)cc1

nearest known ligand 0.84

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.84
HSD17B10 Q99714 3/20 0.84
HIF1A Q16665 2/20 0.84
PTGES O14684 1/20 0.84
ALOX5 P09917 1/20 0.84
CYP2C9 P11712 1/20 0.84
HPGD P15428 1/20 0.84
CASP7 P55210 1/20 0.84
DHODH Q02127 9/20 0.76
EPRS1 P07814 1/20 0.67
KDM4E B2RXH2 2/20 0.63
KMT2A Q03164 1/20 0.62
MAPT P10636 2/20 0.62
PLA2G2A P14555 1/20 0.60
GAA P10253 1/20 0.55
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5529524 0.91 HSD17B10 (0.94) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL14286200 0.91 HSD17B10 (1.00) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL19475477 0.90 HIF1A (0.68) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL1898306 0.87 HSD17B10 (0.86) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL8231321 0.86 DHODH (1.00) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL117422 0.86 PTGES (0.84) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL19475455 0.85 ALDH1A1 (0.73) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL17211764 0.85 ALDH1A1 (0.69) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL23590305 0.85 DHODH (0.97) ALDH1A1HSD17B10HIF1APTGESALOX5
SCHEMBL29617656 0.85 DHODH (0.97) ALDH1A1HSD17B10HIF1APTGESALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 ALDH1A1 1885/4885HSD17B10 4185/4885HIF1A 1348/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 ALDH1A1 1885/4885HSD17B10 4185/4885HIF1A 1348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.